RxSight, Inc. (RXST) shareholders
Close on Nov 13, 2026Market cap $221.28MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 3,491,612 | 8.40% | 13G (passive) amendment | Sep 30, 2026 |
| BlackRock, Inc. | 2,851,023 | 6.90% | 13G (passive) amendment | Sep 30, 2026 |
| Divisadero Street Capital, LLC Joint filing with Divisadero Street Capital Management, LP (6.30%), William Zolezzi (6.30%) and 2 more | 2,531,521 | 6.30% | 13G (passive) | Apr 3, 2025 |
| Point72 Asset Management, L.P. Joint filing with Point72 Capital Advisors, Inc. (6.00%), Steven A. Cohen (6.00%) | 2,487,468 | 6.00% | 13G (passive) | Aug 12, 2026 |
| Israel A. Englander Joint filing with Millennium Management LLC (5.40%), Millennium Group Management LLC (5.40%) | 2,193,062 | 5.40% | 13G (passive) amendment | Sep 30, 2025 |
| Millennium Management LLC Joint filing with Millennium Group Management LLC (5.20%), Israel A. Englander (5.20%) | 2,191,247 | 5.20% | 13G (passive) | Nov 6, 2026 |
| Artisan Investments GP LLC Joint filing with Artisan Partners Asset Management Inc. (5.20%), Artisan Partners Holdings LP (5.20%) and 1 more | 2,157,264 | 5.20% | 13G (passive) | Dec 31, 2025 |
| Millennium Group Management LLC Joint filing with Millennium Management LLC (5.10%), Israel A. Englander (5.10%) | 2,142,052 | 5.10% | 13G (passive) amendment | Sep 30, 2026 |
| Artisan Partners Limited Partnership Joint filing with Artisan Partners Asset Management Inc. (5.00%), Artisan Partners Holdings LP (5.00%) and 1 more | 2,058,684 | 5.00% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of RXST | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,790,408 | 13.92% | $27.91M | +2,603,316 | 0.00% |
| Millennium Management LLC | 3,030,287 | 7.29% | $14.61M | +970,828 | 0.01% |
| No Street GP LP | 2,055,000 | 4.94% | $9.91M | +55,000 | 0.60% |
| Nomura Holdings Inc | 2,000,060 | 4.81% | $9.64M | – | 0.01% |
| D. E. Shaw & Co., Inc. | 1,985,215 | 4.77% | $9.57M | +25,483 | 0.00% |
| Vanguard Capital Management LLC | 1,675,582 | 4.03% | $8.08M | −17,353 | 0.00% |
| Aqr Capital Management LLC | 1,533,826 | 3.69% | $7.39M | +897,697 | 0.00% |
| Acadian Asset Management LLC | 1,501,180 | 3.61% | $7.23M | +482,053 | 0.01% |
| Federated Hermes, Inc. | 1,201,195 | 2.89% | $5.79M | +120,483 | 0.01% |
| Two Sigma Investments, LP | 1,147,048 | 2.76% | $5.53M | −153,212 | 0.00% |
| Healthcare Of Ontario Pension Plan Trust Fund | 1,131,400 | 2.72% | $5.45M | – | 0.01% |
| UBS Group AG | 1,016,066 | 2.44% | $4.90M | +776,610 | 0.00% |
| Jacobs Levy Equity Management, Inc | 998,569 | 2.40% | $4.81M | −67,752 | 0.02% |
| Marshall Wace, Llp | 995,916 | 2.39% | $4.80M | +983,191 | 0.00% |
| Geode Capital Management, LLC | 984,978 | 2.37% | $4.75M | +65,085 | 0.00% |
| State Street Corp | 851,512 | 2.05% | $4.10M | +50,189 | 0.00% |
| Point72 Asset Management, L.P. | 778,252 | 1.87% | $3.75M | +44,945 | 0.00% |
| Grandeur Peak Global Advisors, LLC | 722,440 | 1.74% | $3.48M | +256,848 | 0.81% |
| Schonfeld Strategic Advisors LLC | 701,417 | 1.69% | $3.38M | +509,717 | 0.01% |
| Citadel Advisors LLC | 700,736 | 1.68% | $3.38M | −417,983 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 151 | 41M | 99.6% | 25 / 72 | 35 / 36 | 11M | 8M |
| Q1 2026 | 164 | 38M | 91.8% | 33 / 63 | 54 / 31 | 10M | 6M |
| Q4 2025 | 164 | 37M | 88.2% | 34 / 56 | 56 / 26 | 8M | 5M |
| Q3 2025 | 160 | 33M | 80.2% | 32 / 58 | 56 / 46 | 9M | 13M |
| Q2 2025 | 174 | 38M | 90.6% | 36 / 73 | 40 / 50 | 11M | 9M |
| Q1 2025 | 192 | 37M | 88.1% | 24 / 94 | 47 / 42 | 6M | 4M |
| Q4 2024 | 212 | 35M | 84.9% | 40 / 85 | 61 / 42 | 8M | 7M |
| Q3 2024 | 214 | 34M | 82.1% | 33 / 87 | 66 / 45 | 9M | 7M |
| Q2 2024 | 228 | 35M | 83.8% | 52 / 75 | 79 / 19 | 5M | 5M |
| Q1 2024 | 197 | 35M | 84.0% | 44 / 69 | 64 / 15 | 5M | 3M |
| Q4 2023 | 169 | 33M | 78.8% | 50 / 57 | 45 / 8 | 9M | 3M |
| Q3 2023 | 128 | 27M | 65.8% | 28 / 48 | 33 / 15 | 6M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
132 funds held RXST in Q2 2026, 46% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of RXST | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,227,155 | 2.95% | $5.91M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,028,397 | 2.47% | $4.96M | 0.01% | Jun 30, 2026 |
| Federated Hermes MDT Small Cap Core Fund | 645,556 | 1.55% | $3.88M | 0.17% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund | 433,678 | 1.04% | $2.61M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 409,293 | 0.98% | $1.97M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 335,527 | 0.81% | $1.62M | 0.01% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Growth Fund | 301,631 | 0.73% | $1.45M | 0.01% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 274,343 | 0.66% | $1.46M | 0.03% | May 29, 2026 |
| North Square Dynamic Small Cap Fund | 227,646 | 0.55% | $1.21M | 0.16% | May 31, 2026 |
| Federated Hermes MDT Small Cap Growth Fund | 215,750 | 0.52% | $1.30M | 0.16% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 200,845 | 0.48% | $1.07M | 0.01% | May 31, 2026 |
| Grandeur Peak Global Opportunities Fund | 192,902 | 0.46% | $1.16M | 0.33% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 189,056 | 0.45% | $1.01M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 173,985 | 0.42% | $927.34K | 0.00% | May 31, 2026 |
| Brown Capital Management Small Company Fund | 165,982 | 0.40% | $800.03K | 0.25% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Aziz Mottiwala | President and CEO, Director | – | – | Jul 24, 2026 |
| Eric Weinberg | See remarks | 536,419 | 1.29% | Sep 16, 2026 |
| Mark Wilterding | Chief Financial Officer | 25,049 | 0.06% | Sep 9, 2026 |
| Ilya Goldshleger | Chief Operating Officer | 82,881 | 0.20% | Sep 9, 2026 |
| Ronald M. Kurtz MD | Chief Medical Officer | 836,385 | 2.01% | Sep 9, 2026 |
| Scott Gaines | Chief Customer Officer | 17,428 | 0.04% | Mar 3, 2026 |
| Shelley B. Thunen | See remarks | 38,354 | 0.09% | Apr 15, 2025 |
| Bakker Juliet Tammenoms | Director | 86,731 | 0.21% | Jun 18, 2026 |
| Robert J. Palmisano | Director | 78,076 | 0.19% | Jun 18, 2026 |
| Julie Andrews | Director | 78,076 | 0.19% | Jun 18, 2026 |
| Jesse Anderson Corley | Director | 108,145 | 0.26% | Jun 18, 2026 |
| Robert Keith Warner | Director | 78,076 | 0.19% | Jun 18, 2026 |
| Shweta Maniar | Director | 55,172 | 0.13% | Jun 18, 2026 |
| Tamara Fountain | Director | 72,582 | 0.17% | Jun 18, 2026 |
| Raymond W. Cohen | Director | 66,532 | 0.16% | Jun 18, 2026 |
| William J. Link Phd | Director | 96,140 | 0.23% | Jun 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eric Weinberg See remarks | Sep 15, 2026 | Option exercise | +35,168 | $4.34 | $152.63K | 235,516 |
| Mark Wilterding Chief Financial Officer | Sep 2, 2026 | Sale | −7,765 | $6.96 | $54.04K | 25,049 |
| Eric Weinberg See remarks | Sep 2, 2026 | Sale | −2,041 | $6.96 | $14.21K | 200,348 |
| Ilya Goldshleger Chief Operating Officer | Sep 2, 2026 | Sale | −2,041 | $6.96 | $14.21K | 81,509 |
| Ronald M. Kurtz MD Chief Medical Officer | Sep 2, 2026 | Sale | −5,100 | $6.96 | $35.50K | 71,775 |
| Mark Wilterding Chief Financial Officer | Aug 31, 2026 | Option exercise | +20,441 | – | – | 32,814 |
| Eric Weinberg See remarks | Aug 31, 2026 | Option exercise | +5,370 | – | – | 202,389 |
| Ilya Goldshleger Chief Operating Officer | Aug 31, 2026 | Option exercise | +5,370 | – | – | 83,550 |
| Ronald M. Kurtz MD Chief Medical Officer | Aug 31, 2026 | Option exercise | +13,425 | – | – | 76,875 |
| Tamara Fountain Director | Jun 17, 2026 | Award | +37,037 | – | – | 72,582 |
| Raymond W. Cohen Director | Jun 17, 2026 | Award | +30,864 | – | – | 66,532 |
| Jesse Anderson Corley Director | Jun 17, 2026 | Award | +37,037 | – | – | 86,227 |
| William J. Link Phd Director | Jun 17, 2026 | Award | +37,037 | – | – | 74,892 |
| Bakker Juliet Tammenoms Director | Jun 17, 2026 | Award | +37,037 | – | – | 85,183 |
| Robert J. Palmisano Director | Jun 17, 2026 | Award | +37,037 | – | – | 78,076 |
| Shweta Maniar Director | Jun 17, 2026 | Award | +37,037 | – | – | 55,172 |
| Robert Keith Warner Director | Jun 17, 2026 | Award | +37,037 | – | – | 78,076 |
| Julie Andrews Director | Jun 17, 2026 | Award | +37,037 | – | – | 78,076 |
| Ilya Goldshleger Chief Operating Officer | Apr 17, 2026 | Option exercise | +12,489 | $4.13 | $51.58K | 78,180 |
| Scott Gaines Chief Customer Officer | Feb 28, 2026 | Option exercise | +6,261 | – | – | 17,428 |
| Scott Gaines Chief Customer Officer | Feb 28, 2026 | Tax withholding | −2,580 | $7.61 | $19.63K | 14,848 |
| Mark Wilterding Chief Financial Officer | Feb 28, 2026 | Tax withholding | −8,068 | $7.61 | $61.40K | 12,373 |
| Mark Wilterding Chief Financial Officer | Feb 28, 2026 | Option exercise | +20,441 | – | – | 20,441 |
| Ilya Goldshleger See remarks | Sep 25, 2025 | Option exercise | +15,096 | $4.34 | $65.52K | 57,342 |
| Ilya Goldshleger See remarks | Sep 25, 2025 | Option exercise | +8,349 | $4.13 | $34.48K | 65,691 |
| Raymond W. Cohen Director | Jul 31, 2025 | Award | +35,668 | – | – | 35,668 |
| Robert J. Palmisano Director | Jun 3, 2025 | Award | +10,752 | – | – | 41,039 |
| Jesse Anderson Corley Director | Jun 3, 2025 | Award | +10,752 | – | – | 49,190 |
| Julie Andrews Director | Jun 3, 2025 | Award | +10,752 | – | – | 41,039 |
| Bakker Juliet Tammenoms Director | Jun 3, 2025 | Award | +10,752 | – | – | 48,146 |
| Robert Keith Warner Director | Jun 3, 2025 | Award | +10,752 | – | – | 41,039 |
| William J. Link Phd Director | Jun 3, 2025 | Award | +10,752 | – | – | 37,855 |
| Tamara Fountain Director | Jun 3, 2025 | Award | +10,752 | – | – | 35,545 |
| Shweta Maniar Director | Jun 3, 2025 | Award | +10,752 | – | – | 18,135 |
| Eric Weinberg See remarks | Jun 2, 2025 | Option exercise | +188,002 | $3.93 | $738.85K | 195,351 |
| Shelley B. Thunen See remarks | Apr 14, 2025 | Option exercise | +7,792 | $4.34 | $33.82K | 38,354 |
| Tamara Fountain Director | Mar 12, 2025 | Sale(10b5-1 plan) | −7,000 | $25.71 | $179.97K | 24,793 |
| Shweta Maniar Director | Jan 22, 2025 | Sale(10b5-1 plan) | −3,519 | $30.87 | $108.63K | 7,383 |
| Jesse Anderson Corley Director | Jan 16, 2025 | Buy | +1,767 | $31.13 | $55.01K | 3,210 |
| Jesse Anderson Corley Director | Jan 15, 2025 | Buy | +1,443 | $31.19 | $45.01K | 1,443 |
| Ilya Goldshleger See remarks | Nov 29, 2024 | Sale(10b5-1 plan) | −3,105 | $46.08 | $143.08K | 42,246 |
| Ilya Goldshleger See remarks | Nov 29, 2024 | Option exercise | +3,105 | $15.08 | $46.82K | 45,351 |
| Shweta Maniar Director | Nov 26, 2024 | Sale(10b5-1 plan) | −3,782 | $45.88 | $173.52K | 10,902 |
| Ilya Goldshleger See remarks | Nov 26, 2024 | Option exercise | +3,100 | $15.08 | $46.75K | 45,346 |
| Ilya Goldshleger See remarks | Nov 26, 2024 | Sale(10b5-1 plan) | −3,100 | $45.88 | $142.23K | 42,246 |
| Ilya Goldshleger See remarks | Nov 22, 2024 | Sale(10b5-1 plan) | −3,100 | $45.00 | $139.50K | 42,246 |
| Ilya Goldshleger See remarks | Nov 22, 2024 | Option exercise | +3,100 | $15.08 | $46.75K | 45,346 |
| Ilya Goldshleger See remarks | Nov 18, 2024 | Sale(10b5-1 plan) | −3,067 | $45.00 | $138.02K | 42,279 |
| Ilya Goldshleger See remarks | Nov 18, 2024 | Option exercise | +3,100 | $15.08 | $46.75K | 45,346 |
| Ilya Goldshleger See remarks | Nov 18, 2024 | Sale(10b5-1 plan) | −33 | $45.07 | $1.49K | 42,246 |
| Ilya Goldshleger See remarks | Nov 15, 2024 | Sale(10b5-1 plan) | −4,875 | $46.00 | $224.25K | 42,246 |
| Ilya Goldshleger See remarks | Nov 15, 2024 | Option exercise | +4,875 | $15.08 | $73.52K | 47,121 |
| Jesse Anderson Corley Director | Nov 13, 2024 | Buy | +4,090 | $44.98 | $183.97K | 36,733 |
| Jesse Anderson Corley Director | Nov 13, 2024 | Buy | +1,705 | $44.50 | $75.87K | 38,438 |
| Jesse Anderson Corley Director | Nov 13, 2024 | Buy | +5,570 | $45.00 | $250.65K | 474,141 |
| Jesse Anderson Corley Director | Nov 12, 2024 | Buy | +11,111 | $45.37 | $504.11K | 468,571 |
| Ilya Goldshleger See remarks | Nov 12, 2024 | Sale(10b5-1 plan) | −1,330 | $46.13 | $61.35K | 42,246 |
| Ilya Goldshleger See remarks | Nov 12, 2024 | Option exercise | +1,330 | $15.08 | $20.06K | 43,576 |
| Ilya Goldshleger See remarks | Nov 7, 2024 | Sale(10b5-1 plan) | −200 | $55.53 | $11.11K | 42,246 |
| Ilya Goldshleger See remarks | Nov 7, 2024 | Sale(10b5-1 plan) | −2,900 | $54.96 | $159.38K | 42,446 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of RxSight's stock actually held short. Settlement fails (shares not delivered on time) peaked at 29,603 shares on Sep 22, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ronald M. Kurtz MD Officer | Sep 2, 2026 | 5,100 | $35.50K | Sep 2, 2026 | Restricted Stock Units |
| Mark Wilterding Officer | Sep 2, 2026 | 7,765 | $54.04K | Sep 2, 2026 | Restricted Stock Units |
| Ilya Goldshleger Officer | Sep 2, 2026 | 2,041 | $14.21K | Sep 2, 2026 | Restricted Stock Units |
| Eric Weinberg Officer | Sep 2, 2026 | 2,041 | $14.21K | Sep 2, 2026 | Restricted Stock Units |
| Raymond W. Cohen Former Director | Aug 18, 2026 | 11,890 | $75.75K | Aug 18, 2026 | Restricted Stock |
| Tamara Fountain Director | Mar 12, 2025 | 7,000 | $180.00K | Mar 12, 2025 | Restricted Stock |
| Shweta Maniar Director | Jan 22, 2025 | 3,519 | $108.62K | Jan 22, 2025 | Equity compensation |
| Ilya Goldshleger Officer | Nov 29, 2024 | 3,105 | $143.08K | Nov 29, 2024 | Stock Option Exercise |
| Ilya Goldshleger Officer | Nov 26, 2024 | 3,100 | $142.23K | Nov 26, 2024 | Stock Option Exercise |
| Shweta Maniar Director | Nov 26, 2024 | 3,782 | $173.52K | Nov 26, 2024 | Equity Compensation |
| Ilya Goldshleger Officer | Nov 22, 2024 | 3,100 | $139.50K | Nov 22, 2024 | Stock Option Exercise |
| Ilya Goldshleger Officer | Nov 18, 2024 | 3,100 | $139.50K | Nov 18, 2024 | Stock Option Exercise |
| Ilya Goldshleger Officer | Nov 15, 2024 | 4,875 | $224.25K | Nov 15, 2024 | Stock Option Exercise |
| Ilya Goldshleger Officer | Nov 12, 2024 | 1,330 | $61.36K | Nov 12, 2024 | Stock Option Exercise |
| Ilya Goldshleger Officer | Nov 7, 2024 | 3,100 | $170.49K | Nov 7, 2024 | Stock Option Exercise |
See a number that looks wrong?